Nike vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 84)

Nike

LeaderSporting Goods & Outdoor

Athletic Footwear & Apparel

Beaverton global athletic footwear and apparel (NYSE: NKE) at $51.4B FY2024 revenue with 18% market share; CEO Elliott Hill returned Sept 2024 with Win Now strategy to restore wholesale channels and running category competing with On Running and adidas.

AI VisibilityBeta
Overall Score
A84
Category Rank
#1 of 2
AI Consensus
68%
Trend
stable
Per Platform
ChatGPT
75
Perplexity
78
Gemini
89

About

Nike, Inc. is a Beaverton, Oregon-based global athletic footwear, apparel, and equipment company — publicly traded on the New York Stock Exchange (NYSE: NKE) as a Dow Jones Industrial Average and S&P 500 component — generating $51.4 billion in fiscal year 2024 (ended May 31, 2024) revenue with approximately 83,700 employees worldwide and approximately 18% global athletic footwear market share. Nike brands include Nike (performance footwear, apparel, and equipment), Jordan Brand (lifestyle basketball and athletic), and Converse (lifestyle footwear). In September 2024, Elliott Hill returned to Nike as President and CEO (replacing John Donahoe who had led the company since 2020), launching a "Win Now" strategy focused on sport performance product investment, wholesale partner relationship restoration, and competitive positioning in running and basketball categories. Nike Direct (direct-to-consumer e-commerce and owned stores) generated 44% of FY2024 revenue. Nike was founded in 1964 as Blue Ribbon Sports by Phil Knight and Bill Bowerman; renamed Nike in 1978 with IPO in 1980.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

84
Overall Score
90
#1
Category Rank
#9
68
AI Consensus
60
stable
Trend
stable
75
ChatGPT
99
78
Perplexity
99
89
Gemini
83
80
Claude
96
80
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.